TeleClinic names the 503A pharmacy that compounds its medication and shows the standing NAD+ rate beside the introductory one. It sells one tracked compound, and its headline figure is the promotional one.
What TeleClinic charges
NAD+: $129/mo — the pay-as-you-go monthly rate; the introductory first month is $99
NAD+: $250 — total for the first three months as an introductory price, listed against $319
TeleClinic is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
A named compounder
The pricing footnote says prices reflect compounded medications prepared by licensed 503A pharmacies and names one of them.
That is a checkable fact and it is rarer than it should be. Most sellers here name a regulatory class and stop.
The same pharmacy name appears on another seller reviewed here, which is worth knowing for anyone treating the two as independent quotes.
Introductory and standing, side by side
The NAD+ treatment page prints an introductory first-month figure with the standing rate struck through beside it, and an introductory three-month total with its own comparison figure.
The standing rate is recorded here as the monthly figure, because that is what a subscriber keeps paying. The introductory figure sits in the qualifier.
The three-month introductory total is recorded separately as a prepaid figure rather than divided.
Honest about variation
The site says pricing may vary based on dosage and clinical evaluation, and that a physician must determine eligibility.
It also states plainly that compounded medications are not FDA-approved.
Teleclinic Holdings LLC is named on the homepage, the terms and the privacy policy, which makes the company checkable.
One compound, and the gaps
NAD+ is the only compound tracked here that TeleClinic prices. The rest of its catalogue is GLP-1 medication and vitamin injections.
No list of served states appears.
No certificate of analysis is reachable, and nothing in the live federal warning-letter table attaches to the company or the brand.
Who it's for
Readers who want the compounding pharmacy named.
Shoppers who want the post-promotional price visible before signing up.
Buyers who want a named operating company.
Anyone comparing an introductory month against a three-month intro total.
Who should look elsewhere
Readers who want more than one peptide from a single seller.
Buyers who want the headline figure to be the standing one.
Anyone who needs a published state list.
Shoppers who want published testing.
Strengths
Names Rush Pharmacy as one of the 503A pharmacies that compound its medication
Shows the introductory and standing rate together instead of only the discount
Names Teleclinic Holdings LLC as the operating company
Says pricing may vary by dosage and clinical evaluation rather than implying a fixed rate
Trade-offs
Sells only one tracked compound
Its headline figure is introductory, and the standing rate is 30 per cent higher
Publishes no state list
No certificate of analysis is reachable
How we verified this
Read the NAD+ treatment page and recorded the standing rate as the monthly figure with the introductory rate in its qualifier.
Recorded the three-month introductory total as a prepaid figure rather than dividing it.
Read the pricing footnote for the named pharmacy and set the named-pharmacy flag on that basis.
Recorded that the same pharmacy is named by another seller added in the same pass.
Screened the company and the brand against the live federal warning-letter table with both controls firing in the same run.
A provider to compare TeleClinic against
Trellis Vitality
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.